Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience. (Q30367585)

21 June 2017

1 reference

title

Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience. (English)

1 reference

21 June 2017

0 references

pandemic preparedness

1 reference

1 reference

John Iskander

1

1 reference

21 June 2017

Karen Broder

series ordinal

2

1 reference

21 June 2017

language of work or name

1 reference

1 February 2008

1 reference

Expert Review of Vaccines

21 June 2017

published in

1 reference

21 June 2017

volume

7

1 reference

21 June 2017

issue

1

1 reference

21 June 2017

page(s)

75-82

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

21 June 2017

1 reference

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Avian influenza. 'Pandemic vaccine' appears to protect only at high doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Risk of Anaphylaxis After Vaccination of Children and Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Guillain-Barré syndrome following influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

The science of evaluation of adverse events associated with vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Live attenuated versus inactivated influenza vaccine in infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

The reporting sensitivities of two passive surveillance systems for vaccine adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Population-based study of rotavirus vaccination and intussusception

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Safety of the trivalent inactivated influenza vaccine among children: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Active surveillance of vaccine safety: a system to detect early signs of adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Rapid titration of carvedilol in patients with congestive heart failure: a randomized trial of automated telemedicine versus frequent outpatient clinic visits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Evaluating adverse events after vaccination in the Medicare population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Universal influenza vaccination in the United States: are we ready? Report of a meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

Development of the Vaccine Analytic Unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.75

21 January 2018

Identifiers

DOI

10.1586/14760584.7.1.75

1 reference

21 June 2017

1 reference